Role of dual PET/CT scanning in abdominal malignancies

Cancer Imaging

Volumn 4, Issue 2, 2004, Pages 121-123

  Kalra, Mannudeep K ^a   Blake, Michael A ^a   Saini, Sanjay ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50049122519     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2004.0019     Document Type: Editorial

References (23)

1. Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 2004; 45 (Suppl 1): 82S-95S.
2. Schoder H, Erdi YE, Larson SM, Yeung HW. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 2003; 30: 1419-37.
3. Kluetz PG, Meltzer CC, Villemagne VL et al. Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 2000; 3: 223-30.
4. Benyounes H, Smith FW, Campbell C et al. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma. Nucl Med Commun 1995; 16: 575-80.
5. Inagaki H, Kato T, Tadokoro M et al. Interactive fusion of threedimensional images of upper abdominal CT and FDG PET with no body surface markers. Radiat Med 1999; 17: 155-63.
6. Vogel WV, Oyen WJ, Barentsz JO, Kaanders JH, Corstens FH. PET/CT: panacea, redundancy, or something in between? J Nucl Med 2004; 45 (Suppl 1): 15S-24S.
7. Beyer T, Antoch G, Muller S et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004; 45 (Suppl 1): 25S-35S.
8. Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 2004; 45 (Suppl 1): 56S-65S.
9. Antoch G, Freudenberg LS, Stattaus J. Whole-body positron emission tomography-CT: optimizedCT using oral and IV contrast materials. Am J Roentgenol 2002; 179: 1555-60.
10. Dizendorf EV, Treyer V, Von Schulthess GK, Hany TF. Application of oral contrast media in coregistered positron emission tomography-CT. Am J Roentgenol 2002; 179: 477-81.
11. Goerres GW, Hany TF, Kamel E, von Schulthess GK, Buck A. Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants. Eur J Nucl Med Mol Imaging 2002; 29: 367-70.
12. Goerres GW, Ziegler SI, Burger C, Berthold T, Von Schulthess GK, Buck A. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 2003; 226: 577-84.
13. Bujenovic S, Mannting F, Chakrabarti R, Ladnier D. Artifactual 2-deoxy-2-[(18)F]fluoro-D-glucose localization surrounding metallic objects in a PET/CT scanner using CT-based attenuation correction. Mol Imaging Biol 2003; 5: 20-2.
14. Goerres GW, Burger C, Schwitter MR, Heidelberg TN, Seifert B, von Schulthess GK. PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol 2003; 13: 734-9.
15. Goerres GW, Burger C, Kamel E et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 2003; 226: 906-10.
16. Townsend DW, Cherry SR. Combining anatomy and function: the path to true image fusion. Eur Radiol 2001; 11: 1968-74.
17. Beyer T, Townsend DW, Blodgett TM. Dual-modality PET/CT tomography for clinical oncology. Q J Nucl Med 2002; 46: 24-34.
18. Schoder H, Larson SM, Yeung HW. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 2004; 45 (Suppl 1): 72S-81S.
19. Bar-Shalom R, Leiderman M, Gaitini D et al. The value of PET/CT using FDG in patients with esophageal cancer (abstract). J Nucl Med 2003; 44: 21P.
20. Kalra MK, Maher MM, Boland GW, Saini S, Fischman AJ. Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications. Am J Roentgenol 2003; 181: 387-93.
21. Kaim AH, Burger C, Ganter CC et al. PET-CT-guided percutaneous puncture of an infected cyst in autosomal dominant polycystic kidney disease: case report. Radiology 2001; 221: 818-21.
22. 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003; 44: 1797-803.
23. Yao SZ, Zhang CQ, Chen J, Liu QW, Li QG. Clinical evaluation of 18F-FDG PET-CT in detecting malignant liver tumors. Di Yi Jun Yi Da Xue Xue Bao 2003; 23: 1214-6.